(PubMed) Mills JL, Scott JM, Kirke PN, et al
Figure 1 gives an overview of the physiological actions of GLP-1 and GIP on various organ systems (47)
And today as we speak, our customer base total as on end of April holds almost two-thirds of the Indian market share by value of the generic market We are the first and the only CDMO partner for the first three generic Semaglutide approvals in all the highly regulated markets, US and Canada. Neeraj Sharma, CEO & MD, OneSource Specialty Pharma | Q4 FY26 Gland Pharma is running the same play with cartridges capacity expanded from 40 million to 140 million units a year, eight GLP-1 contracts signed, six or seven more in the pipeline

Symptoms Urinary urgency, frequency, and pain in the absence of infection Lower abdominal pressure Pain upon bladder filling or emptying Painful sex Painful orgasm Generalized pelvic pain Nocturia (waking at night to urinate) Symptoms Urinary urgency, frequency, and pain in the absence of infection Lower abdominal pressure Pain upon bladder filling or emptying Painful sex Painful orgasm Generalized pelvic pain Nocturia (waking at night to urinate) Associated Diagnoses IC/PBS is considered a chronic overlapping pain condition (COPC)